The transition from curing disease to engineering human traits
In short: Genetic modification is moving from science fiction to a looming reality. This talk explores the shift toward using CRISPR technology to create 'designer babies' and the profound, unpredictable consequences of altering our genetic blueprint.
Biologist Paul Knoepfler examines the imminent arrival of human gene editing, estimating that CRISPR technology could be used to modify embryos within fifteen years. The scope of these potential interventions ranges from life-saving medical applications, such as eliminating auto-immune diseases, to aesthetic 'upgrades' like altering physical appearances.
The core of the discussion centers on the ethical gravity of these choices. By moving beyond therapeutic use into elective enhancement, we face a future of personal and unforeseeable consequences that redefine what it means to be human.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: The ethical dilemma of designer babies | Paul Knoepfler
To cite this card, link to https://intellectplus.co.uk/app/ideas-the-ethical-dilemma-of-designer-babies-paul-knoepfler.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Ethics · More in Ideas & Philosophy · Latest · A–Z · All topics
